Caligan Partners, a significant specialty hedge fund, focuses on healthcare investments in the US. They engage in activist strategies, pushing for strategic changes in companies to enhance shareholder value. Y-mAbs Therapeutics, Inc. is one of their top holdings, a biopharmaceutical company showing promising performance.